| Market Cap | 485.50K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -713.07k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
| Sales | 928.49k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -4.00% |
| Dividend | N/A | Price/Book | 0.00 | EPS next 5Y | - | 52W High Chg | -55.00% |
| Recommedations | - | Quick Ratio | 0.04 | Shares Outstanding | 37.35M | 52W Low Chg | - |
| Insider Own | - | ROA | -35.21% | Shares Float | - | Beta | -40.19 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00050 |
| Gross Margin | 13.80% | Profit Margin | -76.80% | Avg. Volume | 3 | Target Price | - |
| Oper. Margin | -77.01% | Earnings Date | - | Volume | 200 | Change | 0.00% |
Quick-Med Technologies, Inc., a life sciences company, focuses on developing and commercializing proprietary broad-based technologies in medical and consumer healthcare markets. It specializes in the research and development of biomedical products and devices for antibacterial applications. The company's core technologies include Novel Intrinsically Micro-Bonded Utility Substrate (NIMBUS), a family of advanced polymers with antimicrobial, hemostatic, and other properties for use in a range of applications; Stay Fresh, a chemical formulation for textiles with a durable antimicrobial agent effective against an array of bacteria; and MultiStat, a family of advanced patented methods and compounds effective in skin therapy applications. It serves government agencies; and healthcare and medical, apparel and textile, and personal care companies. The company was founded in 1997 and is headquartered in Gainesville, Florida.